A Long-Term, Open-Label Safety and Efficacy Study of Xyrem (sodium oxybate) in Subjects with Fibromyalgia

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-006291-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to assess the safety of Xyrem (sodium oxybate) in long term use (up to 38 weeks) in subjects completing a double-blind controlled trial of Xyrem for the treatment of fibromyalgia.


Critère d'inclusion

  • Fibromyalgia